← All trials
NCT05433298
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 1, 2022
- Primary completion
- Nov 26, 2022
- Completion date
- Dec 31, 2022
- First posted
- Jun 27, 2022
- Last posted
- Jun 27, 2022
- Enrollment
- 60
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Pontifícia Universidade Católica do ParanáLead sponsor
- Conselho Nacional de Desenvolvimento Científico e TecnológicoCollaborator
- Pontifícia Universidade Católica do ParanáOverall official - principal investigator
- Pontifícia Universidade Católica do ParanáSponsor investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.